Markets:

Overview

News

Currencies

International

Treasuries

Opko Health, Inc. - Common Stock (NQ:OPK)

1.180 +0.000 (+0.02%)

Streaming Delayed Price Updated: 10:50 AM EDT, Jul 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Opko Health, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

OPKO Health And 2 More Stocks Under $3 Insiders Are Aggressively Buying ↗

June 27, 2022

The Dow Jones surged by more than 800 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

9 Stock Picks With Important Insider Trading Signals to Buy Now ↗

June 07, 2022

Bullish insider trading transactions are intriguing for formulating stock picks, particularly during a corrective period in the markets.

Via InvestorPlace

Executives Buy Around $1.5M Of 4 Penny Stocks ↗

May 12, 2022

US stock futures traded lower this morning on Thursday ahead of the producer price index. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

11 Stocks Moving Towards A VWAP Breakout: Tellurian, SM Energy, Freshworks And More ↗

April 12, 2022

Volume-weighted average price or VWAP is the ratio of total volume traded divided by the total volume traded for a chosen time frame. VWAP is an important indicator for intraday trading as it...

Via Benzinga

103 Biggest Movers From Yesterday ↗

May 11, 2022

Gainers

Via Benzinga

77 Stocks Moving In Tuesday's Mid-Day Session ↗

May 10, 2022

Gainers

Via Benzinga

Executives Buy Around $2M Of 5 Penny Stocks ↗

March 16, 2022

Crude oil futures traded higher by around 2% on Wednesday. Investors, meanwhile, focused on some notable insider trades When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 25, 2022

During Friday's trading, 54 companies set new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company by market cap to hit a new 52-week...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 25, 2022

Gainers Kaleido Biosciences (NASDAQ:KLDO) stock rose 14.6% to $1.73 during Friday's pre-market session. The market value of their outstanding shares is at $73.6...

Via Benzinga

The Daily Biotech Pulse: Lilly's Jardiance Gets Nod For Heart Failure, Pulmatrix Announces Reverse Split, Reata Awaits FDA Decision ↗

February 25, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Lilly's Co-developed Diabetes Drug Jardiance Gets Label Expansion To...

Via Benzinga

32 Stocks Moving in Friday's Pre-Market Session ↗

February 25, 2022

Gainers Cyren Ltd. (NASDAQ: CYRN) rose 54.6% to $7.48 in pre-market trading after gaining around 119% on Thursday. The company recently announced a $12 million private placement...

Via Benzinga

Recap: OPKO Health Q4 Earnings ↗

February 24, 2022

OPKO Health (NASDAQ:OPK) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings OPKO...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 24, 2022

Gainers Unicycive Therapeutics (NASDAQ:UNCY

Via Benzinga

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗

February 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...

Via Benzinga

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

7 Insider Stocks to Buy as Execs Snap Them Up ↗

February 18, 2022

With equity prices soaring to record levels, many execs have cashed out. Here are the insider stocks where execs are cashing in.

Via InvestorPlace

Executives Buying These 5 Penny Stocks ↗

February 16, 2022

Although US stock futures traded slightly lower this morning, there were a few notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the...

Via Benzinga

Pfizer and OPKO’s Once-Weekly NGENLA™ (somatrogon) Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency

February 15, 2022

From Pfizer Inc.

Via Business Wire

10 Best Stocks to Buy for Your Income-Generating Portfolio ↗

January 28, 2022

These 10 stocks to buy provide you with a dividend-income ladder from 1% to 10% yields. And hopefully some capital appreciation as well

Via InvestorPlace

Mid-Afternoon Market Update: Nasdaq Down 250 Points; OPKO Health Shares Plunge ↗

January 24, 2022

Toward the end of trading Monday, the Dow traded down 1.84% to 33,636.46 while the NASDAQ fell 1.83% to 13,517.61. The S&P also fell, dropping, 1.98% to 4,310.71. The U.S. has...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

January 25, 2022

On Tuesday, 88 companies set new 52-week lows. Interesting Highlights From Today's 52-Week Lows: Credit Suisse Group (NYSE:CS) was the largest, in terms of market cap...

Via Benzinga

Mid-Day Market Update: Dow Dips 1000 Points; Exterran Shares Jump ↗

January 24, 2022

Midway through trading Monday, the Dow traded down 3.09% to 33,205.52 while the NASDAQ fell 4.56% to 13,141.60. The S&P also fell, dropping, 3.82% to 4,230.05. The U.S. has...

Via Benzinga

65 Biggest Movers From Yesterday ↗

January 25, 2022

Gainers Exterran Corporation (NYSE: EXTN) shares surged 59.7% to close at $4.79 on Monday after the company said it would merge with Enerflex to create a premier integrated...

Via Benzinga

Pfizer Dives After FDA Rejects Its OPKO-Partnered Rare Disease Treatment ↗

January 24, 2022

Pfizer stock tumbled after the FDA rejected an OPKO-partnered drug.

Via Investor's Business Daily

54 Stocks Moving In Monday's Mid-Day Session ↗

January 24, 2022

Gainers Exterran Corporation (NYSE: EXTN) shares jumped 52.4% to $4.5720 after the company said it would merge with Enerflex to create a premier integrated global provider of...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 24, 2022

Gainers SAB Biotherapeutics (NASDAQ:SABS) stock moved upwards by 15.0% to $6.3 during Monday's pre-market session. The market value of their outstanding shares is at $...

Via Benzinga

Benzinga Pro's Top 5 Stocks To Watch For Monday, Jan. 24, 2022: UL, SNAP, OPK, M, IBM ↗

January 24, 2022

Today's 5 Stock Ideas: Unilever (UL) - Shares rose following a media report that hedge fund Trian Partners has built a stake in the company. Snap (SNAP) - Wedbush...

Via Benzinga

28 Stocks Moving in Monday's Pre-Market Session ↗

January 24, 2022

Gainers BT Brands, Inc. (NASDAQ: BTBD) shares rose 158% to $6.37 in pre-market trading after declining around 12% on Friday. Kohl's Corporation (NYSE: KSS) rose 28.4% to $60...

Via Benzinga

A Peek Into The Markets: US Stock Futures Down Following Friday's Plunge ↗

January 24, 2022

Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones tumbled 450 points in the previous session. Investors are awaiting earnings results...

Via Benzinga

Pfizer - OPKO Health's Growth Hormone Deficiency Candidate Receives FDA Response Letter ↗

January 24, 2022

The FDA has issued a Complete Response Letter (CRL) to Pfizer Inc (NYSE: PFE) and OPKO Health Inc's (NASDAQ: OPK) somatrogon. Somatrogon...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.